New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
Hidden Immune Gene Linked to Rare Neurological Movement Disorder
Scientists discovered that CD99L2, a gene previously linked only to immune function, causes rare movement disorders. Analysis of nearly 3,000…
Editor's Top Picks
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood Disorder
First clinical trial of in vivo CRISPR gene editing for hereditary angioedema shows promising results. The investigational therapy targets genetic…
Submit Your Paper →
More form New Studies
Diabetes Drug Dapagliflozin Cuts Heart Failure Risk by 32% in Genetically Vulnerable Patients
New research shows dapagliflozin reduces heart failure risk by 32% in patients with cardiomyopathy-associated genetic…
New NEJM Trial Shows Romiplostim Reduces Chemotherapy-Induced Thrombocytopenia Risk
A randomized controlled trial in NEJM shows romiplostim significantly reduces chemotherapy-induced thrombocytopenia compared to placebo.…
New Study Challenges Safety Assumptions About NSAIDs in Early Pregnancy
New PLOS Medicine analysis reveals the complex relationship between NSAID use and birth defects during…
Finerenone Shows Cardiovascular Benefits in Non-Diabetic Chronic Kidney Disease Patients
Finerenone significantly reduces cardiovascular events by 14% in non-diabetic chronic kidney disease patients, according to…
Pediatric influenza hospitalizations nearly doubled post-pandemic, Canadian surveillance finds
Canadian surveillance study reveals pediatric influenza hospitalizations nearly doubled in 2022–2023, with age distribution shifting…